31078244Dwadasi S, Israel A, Rubin DTGastrointestinal endoscopy clinics of North AmericaAntibodies, Monoclonal; Gastrointestinal Agents; Inflammatory Bowel Diseases; Tumor Necrosis Factor-alphaAdalimumab; Biosimilar Pharmaceuticals; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness IndexThe Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know? Gastrointest Endosc Clin N Am. 2019 Jul; 29(3):405-419.Gastrointest Endosc Clin N Am2019-04-12T00:00:002019The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?plugins:TwitterTwitterprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD005765Chemicals & Drugs391610.85937Gastrointestinal AgentsD007166Chemicals & Drugs2179770.66626Immunosuppressive AgentsD004359Procedures2748930.819188Drug Therapy, CombinationAuthorship 12961330.7090220.7090221authors10.2515has subject areaD006801Living Beings2262862810.130052HumansD014409Chemicals & Drugs2356830.750704Tumor Necrosis Factor-alphaD015212Disorders1075460.616857Inflammatory Bowel DiseasesD010880Chemicals & Drugs951810.872271PiperidinesD011743Chemicals & Drugs1373700.795259PyrimidinesD011758Chemicals & Drugs621840.890788PyrrolesD012720Concepts & Ideas54117960.64922Severity of Illness IndexD059451Chemicals & Drugs10200.964953Biosimilar PharmaceuticalsD00006887913800.940334AdalimumabD000069285311510.943714Infliximabhttps://rubinlab.uchicago.edu/Rubin Lab Sitehttps://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-diseaseInflammatory Bowel Disease CenterIBDMDD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsMedicineUniversity of ChicagoDavid T.RubinDavid T. Rubin41.78927490000000-87.60125000000000256Rubin, David T.Professortrue1ProfessorProfessor